2013, Number 3
Evaluation of the program of prenatal detection of chromosomic anomalies by cytogenetic studies
Language: Spanish
References: 15
Page:
PDF size: 83.28 Kb.
ABSTRACT
Introduction: the prenatal cytogenetic diagnosis is an effective diagnostic option to know the fetal chromosome complement. Amniocentesis as an obstetric procedure to obtain fetal cells began performing in Mayabeque province in 2010.Objective: to describe the results of the prenatal detection program of chromosomic anomalies by cytogenetic studies in Mayabeque province in 2011 and 2012.
Methods: it was performed a descriptive, retrospective and longitudinal study that included the total of pregnant women who were indicated prenatal cytogenetic diagnosis in the aforementioned period. Data were obtained from the records of cytogenetics of Mayabeque Provincial Center of Medical Genetics and the clinical histories of each pregnant woman. Different variables were analyzed, including: maternal age, motive for study indication, number of performed diagnoses and types of detected anomalies.
Results: of the 549 patients with cytogenetic study criteria 89.1 % corresponded to pregnant women with advanced maternal age. 477 patients underwent the procedure (86.9%) and within the major causes of failure to complete it, it was found the non-request of the procedure (48.6%). Among the positive results 54.5% corresponded to aneuploidies caused by trisomies in chromosomes 13 and 21.
Conclusions: with the prenatal cytogenetic diagnosis it was possible to specify the fetal chromosome complement in pregnant women at risk and in positive cases a highest quality genetic counseling was achieved.
REFERENCES
Méndez Rosado LA, Morales Rodríguez E, Quiñonez Maza O, Barrios Martinez A, Oliva Rodríguez JA, Nodarse Rodríguez A, et al. Aniversario 30 del diagnóstico prenatal citogenético en La Habana [Internet]. La Habana: Cuba Salud; 2012 [citado 2 abr 2013]. Disponible en: http://www.convencionsalud2012.sld.cu/index.php/convencionsalud/2012/paper/v iew/585/261
Cerrillo Hinojosa M, Yerena de Vega MC, González Panzzi ME, Godoy H, Galicia J, Gutiérrez Májar A. Amniocentesis genética en población de alto riesgo. Experiencia en 3,081 casos. Ginecol Obstet Mex [Internet]. 2009 [citado 2 abr 2013];77(4). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19496509
Pimentel Benítez HI, García Borrego A, Martín Cuesta N, Alonso Barba Y, Torres Palacios M, Suárez Mayedo U. Diagnóstico prenatal citogenético en Camagüey. Resultados de 20 años. Rev Cubana Genet Comunit [Internet]. 2008 [citado 2013 Abr 2];2(3). Disponible en: http://bvs.sld.cu/revistas/rcgc/v2n3/PDFs%20Infomed/rcgc07308.pdf
Soler-Casas A, Sánchez-Díaz A, Morales-Peydró C. Impacto del diagnóstico prenatal en la prevención del retraso mental de causa cromosómica. Alteraciones cromosómicas detectables mediante diagnóstico prenatal. Rev Neurol [Internet]. 2006 [citado 2013 Abr 2];42(1). Disponible en: http://www.revneurol.com/LinkOut/formMedLine.asp?Refer=2005705&Revista=Re vNeurol
Martínez de Santelices Cuervo A, Rizo López D, Amor Oruña MT, Fuentes Smith LE. Eficiencia del subprograma de Diagnóstico Prenatal Citogenético en Ciudad de La Habana en el período 2005-2006. Rev Cubana Genet Comunit [Internet]. 2010 [citado 2013 Abr 2];4(3). Disponible en: http://bvs.sld.cu/revistas/rcgc/v4n3/rcgc080310.pdf
Demirturk F, Caliskan AC, Aytan H, Sahin S. A preliminary retrospective study about the relationship between ductus venosus Doppler indices, nuchal translucency (NT) and biochemical markers in the first and second trimester screening tests. Gynecol Endocrinol [Internet]. 2012 [citado 2013 abr 2];28(5). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22364171
Wallerstein R, Yu MT, Neu RL, Benn P, Bowen CL, Crandall B, et al. Common trisomy mosaicism diagnosed in amniocytes involving chromosomes 13, 18, 20 and 21: karyotypephenotype correlations. Prenat Diagn [Internet]. 2000 [citado 2013 abr 2];20. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/10694683